Equities
FinancialsNon-life Insurance
  • Price (USD)267.59
  • Today's Change2.95 / 1.11%
  • Shares traded39.59k
  • 1 Year change+23.70%
  • Beta0.3934
Data delayed at least 15 minutes, as of Nov 22 2024 16:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy3
Outperform4
Hold6
Sell1
Strong Sell0

Share price forecast in USD

The 11 analysts offering 12 month price targets for Renaissancere Holdings Ltd have a median target of 287.00, with a high estimate of 410.00 and a low estimate of 246.00. The median estimate represents a 8.45% increase from the last price of 264.64.
High54.9%410.00
Med8.4%287.00
Low-7.0%246.00

Dividends in USD

In 2023, Renaissancere Holdings Ltd reported a dividend of 1.52 USD, which represents a 2.70% increase over last year. The 6 analysts covering the company expect dividends of 1.58 USD for the upcoming fiscal year, an increase of 3.82%.
Div growth (TTM)2.70%
More ▼

Earnings history & estimates in USD

On Nov 06, 2024, Renaissancere Holdings Ltd reported 3rd quarter 2024 earnings of 10.23 per share. This result exceeded the 7.75 consensus of the 13 analysts covering the company and exceeded last year's 3rd quarter results by 22.81%.
The next earnings announcement is expected on Jan 28, 2025.
Average growth rate+7.28%
Renaissancere Holdings Ltd reported annual 2023 earnings of 37.54 per share on Jan 30, 2024.
Average growth rate+493.33%
More ▼

Revenue history & estimates in USD

RenaissanceRe Holdings Ltd. had 3rd quarter 2024 revenues of 2.58bn. This missed the 2.60bn consensus estimate of the 4 analysts following the company. This was 53.70% above the prior year's 3rd quarter results.
Average growth rate+10.59%
RenaissanceRe Holdings Ltd. had revenues for the full year 2023 of 7.47bn. This was 17.95% above the prior year's results.
Average growth rate+15.77%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.